| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 20/11/2024 | 23:11 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SIBN | SI BONE Inc |
| 20/11/2024 | 22:09 | GlobeNewswire Inc. | SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024 | NASDAQ:SIBN | SI BONE Inc |
| 14/11/2024 | 22:43 | Edgar (US Regulatory) | Form SC 13G - Statement of Beneficial Ownership by Certain Investors | NASDAQ:SIBN | SI BONE Inc |
| 12/11/2024 | 23:00 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:SIBN | SI BONE Inc |
| 12/11/2024 | 22:13 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SIBN | SI BONE Inc |
| 12/11/2024 | 22:09 | GlobeNewswire Inc. | SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance | NASDAQ:SIBN | SI BONE Inc |
| 05/11/2024 | 14:30 | GlobeNewswire Inc. | SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite™ | NASDAQ:SIBN | SI BONE Inc |
| 22/10/2024 | 22:09 | GlobeNewswire Inc. | SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024 | NASDAQ:SIBN | SI BONE Inc |
| 10/10/2024 | 14:30 | GlobeNewswire Inc. | SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation | NASDAQ:SIBN | SI BONE Inc |
| 03/09/2024 | 22:21 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:SIBN | SI BONE Inc |
| 22/08/2024 | 22:30 | GlobeNewswire Inc. | SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024 | NASDAQ:SIBN | SI BONE Inc |
| 20/08/2024 | 14:30 | GlobeNewswire Inc. | SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System | NASDAQ:SIBN | SI BONE Inc |
| 07/08/2024 | 22:55 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:SIBN | SI BONE Inc |
| 06/08/2024 | 14:30 | GlobeNewswire Inc. | SI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024 | NASDAQ:SIBN | SI BONE Inc |
| 05/08/2024 | 22:09 | GlobeNewswire Inc. | SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024 | NASDAQ:SIBN | SI BONE Inc |
| 15/07/2024 | 22:09 | GlobeNewswire Inc. | SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024 | NASDAQ:SIBN | SI BONE Inc |
| 05/06/2024 | 22:09 | GlobeNewswire Inc. | SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024 | NASDAQ:SIBN | SI BONE Inc |
| 07/05/2024 | 15:00 | GlobeNewswire Inc. | SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures | NASDAQ:SIBN | SI BONE Inc |
| 06/05/2024 | 22:09 | GlobeNewswire Inc. | SI-BONE, Inc. Reports Financial Results for the First Quarter 2024 | NASDAQ:SIBN | SI BONE Inc |
| 29/04/2024 | 15:00 | GlobeNewswire Inc. | SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024 | NASDAQ:SIBN | SI BONE Inc |
| 15/04/2024 | 22:09 | GlobeNewswire Inc. | SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024 | NASDAQ:SIBN | SI BONE Inc |
| 04/03/2024 | 22:09 | GlobeNewswire Inc. | SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024 | NASDAQ:SIBN | SI BONE Inc |
| 27/02/2024 | 22:31 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:SIBN | SI BONE Inc |
| 27/02/2024 | 22:03 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:SIBN | SI BONE Inc |
| 26/02/2024 | 22:09 | GlobeNewswire Inc. | SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance | NASDAQ:SIBN | SI BONE Inc |
| 14/02/2024 | 23:07 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:SIBN | SI BONE Inc |
| 05/02/2024 | 22:09 | GlobeNewswire Inc. | SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024 | NASDAQ:SIBN | SI BONE Inc |
| 30/01/2024 | 14:30 | GlobeNewswire Inc. | SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application | NASDAQ:SIBN | SI BONE Inc |
| 08/01/2024 | 14:30 | GlobeNewswire Inc. | SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023 | NASDAQ:SIBN | SI BONE Inc |
| 14/11/2023 | 22:09 | GlobeNewswire Inc. | SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023 | NASDAQ:SIBN | SI BONE Inc |